A new monoclonal antibody, SM3, against stripped mucin core protein has been evaluated for the radioimmunoscintigraphy of ovarian cancer. It was radiolabelled with In-111, I-123 and Tc-99m and results showed a sensitivity of 95%, 100% and 100% and an accuracy of 73%, 86% and 100% for malignancy; respectively.
BlaquiereR.M., HusbandJ.E.Conventional radiology and computer tomography in ovarian cancer. J Roy Soc Med1983; 76: 574–9.
2.
CalkinsA.R., StehmanF.B., WassJ.L.Pitfalls in interpretation of computed tomography prior to second-look laparotomy in patients with ovarian cancer. Brit J Radiol.1987: 60: 975–9.
3.
KhanO., CosgroveD.O., WiltshawK.Role of ultrasound in the management of ovarian cancer. J Roy Soc Med1983; 76: 821–7.
4.
EpenetosA.A., MatherS.J., BrittonK.E.Targetting of iodine-123-labelled tumor associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet1982; ii: 999–1004.
5.
GranowskaM., ShepherdJ., BrittonK.E.Ovarian cancer: diagnosis using 123-1 monoclonal antibody in comparison with surgical findings. Nucl Med Commun1984; 5: 485–99.
6.
GranowskaM., BrittonK.E., ShepherdJ.The detection of ovarian cancer using 123-1 monoclonal antibody. Radiobiol Radiother (Berlin)1984; 25: 153–60.
7.
GranowskaM., BrittonK.E., ShepherdJ.H.A prospective study of 123-1 labelled monoclonal antibody imaging in ovarian cancer. J Clin Oncol1986; 4: 730–6.
8.
GranowskaM., BrittonK.E., CrowtherM.Kinetic analysis with probability mapping in radioimmunoscintigraphy. In: SrivastavaSC, ed. Radiolabelled monoclonal antibodies for imaging and therapy. Nato Advanced Study Institute, New York: Plenum Press1988; 311–22.
9.
GranowskaM., NimmonC.C., BrittonK.E.Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J Nucl Med1988; 29: 599–607.
10.
Taylor-PapadimitriouJ., PetersonJ.A., ArklieJ.Monoclonal antibodies to epithelium specific components of the human milk fat globule membrane production and reaction with cells in culture. Int J Cancer1981; 28: 17–21.
11.
BurchellJ., GendlerS., Taylor-PapadimitriouJ.Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res1987; 47: 5476–82.
12.
GirlingA., BartkovaJ., BurchellJ.Immunohisto-chemical evaluation of a monoclonal antibody directed to the core protein of the human milk mucin; staining patterns in normal human tissues and primary carcinomas. Int J Cancer (in press).
13.
Taylor-PapadimitriouJ., BurchellJ., GendlerS.Epithelial mucin antibodies and their epitopes. Core protein epitopes of a polymorphic epithelial mucin (PEM). Proceeding of 3rd International Workshop on Monoclonal antibodies and breast cancer. Nov 1988, San Francisco, California.
14.
BurchellJ., Taylor-PapadimitriouJ., BoshellM.A short sequence, within the amino acid tandem repeat of a cancer associated mucin, contains immunodominant epitopes. Int J Cancer1989; 44: 4486–94.
15.
HanischF.G., UhlenbruckG., Peter-KatalinicJ.Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyl-lactosamine backbones with GalB (1-4) GlcNAcB (1-6) repeating units. J Biol Chem1989; 264: 872–83.
16.
HullS.R., BrightA., CarrawayK.L.Oligosaccharides of the DF3 antigen of the BT-20 human breast carcinoma cell line. J Cell Biochem1988; suppl 12E: 130.
17.
GranowskaM., MatherS.J., BrittonK.E.SM3, a new monoclonal antibody for radioimmunoscintigraphy of ovarian tumours. J Nucl Med1989; 30: 758.
18.
BegentR.H.J.Working party on the clinical use of antibodies: operations manual. Brit J Cane1986; 54: 557–68.
19.
CompbellS., BhanV., RoystonP.Trans abdominal ultrasound screening for early ovarian cancer. Brit Med J1989; 229: 1363–7.
